Feed / UNH

UnitedHealth Group Incorporated

UNH

Healthcare · 378.87 -2.4% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:55 GMT-4

Market read

UnitedHealth Group Incorporated's current read is isolated; its market group is not confirming.

The latest filing is mixed. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.

What changed
  • Revenue increased 2.0% versus the comparable filing period.
Company-2.4% todayVolume comparison unavailable
Market group0 of 7 activeHealthcare Plans · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Pricing trends drove the revenue increase while fewer people were served, making pricing a key offset to volume pressure.

Invalidation: The isolated read changes if UNH's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Healthcare Plans

The latest filing is mixed. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 2.0% versus the comparable filing period.
  • Operating cash flow covered net income at 1.42x, improving versus the comparable period.
Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • Pricing trends drove the revenue increase while fewer people were served, making pricing a key offset to volume pressure.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations602
Usable filing statements113
Verified relationships8
Evidence supporting the case
  • Latest annual revenue changed +11.8% year over year.
Evidence challenging the case
  • Operating margin changed -3.8 percentage points in the latest annual period.
  • Demand and volume has repeated adverse evidence across 3 filings.
Questions before a position
  • EV/sales is 216% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 11, 2026

378.87
6m+36.7%12m+9.3%24m-36.6%
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$287.6B+11.8%$18.08-0.5%
2022-12-31$324.2B+12.7%$21.18-0.6%
2023-12-31$371.6B+14.6%$23.86-1.3%
2024-12-31$400.3B+7.7%$15.51-1.0%
2025-12-31$447.6B+11.8%$13.23-1.9%

What management says matters

Persistent and emerging business drivers

Macroeconomic conditionspositive · 5 filings
We expect overall spending on health care to continue to grow in the future, due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being.
10-Q · Aug 10, 2026
Legal and regulatory exposuremixed · 4 filings
As of March 31, 2026, we have entered into agreements to acquire companies in the health care sector, subject to regulatory approval and customary closing conditions, the majority of which are expected to close in the second half of 2026.
10-Q · May 5, 2026
Demand and volumemixed · 3 filings
Optum Insight Revenues at Optum Insight increased due to elevated investment and other income and growth in technology services, partially offset by lower volumes within business services.
10-Q · May 5, 2026
Pricing and mixnegative · 3 filings
UnitedHealthcare served 1.6 million fewer people due to benefit design and pricing actions and reduced Medicaid eligibility and the exit from one state.
10-Q · Aug 10, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 0.8× · EV/sales 0.9×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

378.87-2.4% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for UNH. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

The latest filing presents a mixed picture

10-Q filed 2026-05-05 against the comparable filing from 2025-05-07.

mixed
OperationsmixedEvidence score +1
liquidityconstructiveEvidence score +1
valuationmixed

What improved

  • Revenue increased 2.0% versus the comparable filing period.
  • Operating cash flow covered net income at 1.42x, improving versus the comparable period.

What weakened

No thresholded deterioration was identified.

Filing receipts

Operating Cost Ratio The operating cost ratio increased primarily due to investments in people, process and technology to drive improved consumer and care provider experiences and greater operating efficiencies; business mix and the impacts of restructuring and other actions; partially offset by the revenue impacts of government programs, operating cost management and net portfolio divestitures in 2026.

Operating Cost Ratio The operating cost ratio increased primarily due to investments in people, process and technology to drive improved consumer and care provider experiences and greater operating efficiencies; business mix and the impacts of restructuring and other actions;

thin businesses held for sale 170 (91) 261 Net increase in cash and cash equivalents $ 3,636 $ 5,405 $ (1,769) 2026 Cash Flows Compared to 2025 Cash Flows Increased cash flows provided by operating activities were driven by legislative changes from the Inflation Reduction Act impacting pharmacy rebates and other changes in working capital accounts.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind UNH

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depended on by

HQYHealthEquity, Inc.competitorMay 28, 2026

Some of our direct competitors (including well-known retail investment companies, such as Fidelity Investments, and healthcare service companies such as UnitedHealth Group's Optum and Webster Bank ) are in a position to devote more resources to the developmen…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

UNH is currently a Leader in the organic co-movement group Healthcare Plans. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.